| Literature DB >> 34065566 |
María Luisa Díaz-Bertrana1, Stefan Deleuze2, Lidia Pitti Rios3, Marc Yeste4, Inmaculada Morales Fariña1, Maria Montserrat Rivera Del Alamo5.
Abstract
Entities:
Keywords: early estrus; equine endometritis; microbiologic study; sensitivity test
Year: 2021 PMID: 34065566 PMCID: PMC8160901 DOI: 10.3390/ani11051476
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Percentage of Gram+, Gram– and yeasts in the 347 isolates obtained from the 323 positive mares included in the study.
Combinations of yielded mixed growth.
| Microorganisms Combination | Number of Mares (out of 22) |
|---|---|
|
| 8 |
|
| 4 |
|
| 3 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
|
| 1 |
Prevalence of bacteriological examinations yielded from uterine swabs.
| Microorganism | Number of Isolates | Frequency (%) |
|---|---|---|
|
| 60 | 17.3 |
| 54 | 15.6 | |
| 47 | 13.5 | |
|
| 23 | 6.6 |
| 19 | 5.5 | |
|
| 16 | 4.6 |
|
| 12 | 3.5 |
|
| 11 | 3.2 |
|
| 8 | 2.3 |
|
| 8 | 2.3 |
| 8 | 2.3 | |
| 8 | 2.3 | |
|
| 7 | 2.0 |
| 6 | 1.7 | |
|
| 6 | 1.7 |
| 5 | 1.4 | |
|
| 5 | 1.4 |
| 4 | 1.2 | |
|
| 4 | 1.2 |
|
| 4 | 1.2 |
|
| 3 | 0.9 |
| 3 | 0.9 | |
| 3 | 0.9 | |
|
| 3 | 0.9 |
|
| 2 | 0.6 |
| 2 | 0.6 | |
| 2 | 0.6 | |
| 2 | 0.6 | |
|
| 2 | 0.6 |
|
| 2 | 0.6 |
|
| 2 | 0.6 |
|
| 1 | 0.3 |
|
| 1 | 0.3 |
|
| 1 | 0.3 |
|
| 1 | 0.3 |
|
| 1 | 0.3 |
|
| 1 | 0.3 |
Overall results of sensitivity to each evaluated antibiotic. Statistically significant differences (p < 0.05) among the response to sensitivity test for each antimicrobial drug are marked with different superscripts.
| Antibiotic | Sensitive (%) | Intermediate (%) | Resistant (%) |
|---|---|---|---|
| Amikacin | 57.3 a | 22.7 b | 20.0 c |
| Cefoxitin | 48.6 a | 24.5 a | 26.9 b |
| Gentamicin | 48.3 a | 17.4 b | 34.3 b |
| Trimethoprim/sulphonamide | 38.7 ab | 20.3 a | 41.0 b |
| Kanamycin | 37.8 ab | 21.2 a | 41.0 b |
| Neomycin | 33.4 a | 29.1 b | 37.5 c |
| Amoxicillin/clavulanic acid | 33.4 a | 11.3 b | 55.3 a |
| Oxytetracycline | 32.8 a | 30.6 b | 36.7 a |
| Ticarcillin | 32.0 a | 14.8 a | 53.2 a |
| Ampicillin | 22.4 a | 15.7 a | 61.9 b |
| Apramycin | 18.3 a | 16.9 b | 64.8 c |
| Penicillin | 17.2 a | 7.6 a | 75.2 b |
| Cephaloridine | 16.9 a | 4.9 b | 78.2 c |
| Doxycycline | 14.5 a | 32.0 b | 53.5 c |
Figure 2Antimicrobial susceptibility for Gram+ microorganisms. Results are expressed as percentages. GM: gentamicin; AK: amikacin; AMP: ampicillin; P: penicillin; D: doxycycline; K: kanamycin; N: neomycin; APR: apramycin; TIC: ticarcillin; AMC: amoxicillin/clavulanic acid; CR: cephaloridine; SXT: trimethoprim-sulphonamide; FOX: cefoxitin; OT: oxytetracycline.
Figure 3Antimicrobial susceptibility for Gram– microorganisms. Results are expressed in terms of percentage. GM: gentamicin; AK: amikacin; AMP: ampicillin; P: penicillin; D: doxycycline; K: kanamycin; N: neomycin; APR: apramycin; TIC: ticarcillin; AMC: amoxicillin/clavulanic acid; CR: cephaloridine; SXT: trimethoprim-sulphonamide; FOX: cefoxitin; OT: oxytetracycline.
Sensitivity results of the different antibiotic drugs, expressed in percentages, for the main yielded microorganisms. Statistically significant differences (p < 0.05) among the response to sensitivity test for each microorganism and antimicrobial drug are marked with different superscripts.
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S | IM | R | S | IM | R | S | IM | R | S | IM | R | |
| GM | 53.3 a | 20.0 ab | 26.7 b | 40.7 a | 18.5 a | 40.7 a | 44.7 a | 12.8 a | 42.6 a | 56.5 a | 21.7 a | 21.7 a |
| AK | 63.3 a | 28.3 a | 8.3 b | 48.1 a | 24.1 ab | 27.8 b | 46.8 a | 25.5 a | 27.7 a | 78.3 a | 17.4 ab | 4.3 ab |
| AMP | 16.7 a | 20.0 ab | 63.3 b | 38.9 a | 13.0 a | 48.1 a | 25.5 a | 19.1 a | 55.3 a | 17.4 a | 13.0 a | 69.6 a |
| P | 13.3 a | 8.3 a | 78.3 b | 27.8 ab | 7.4 b | 64.8 a | 38.3 ab | 6.4 b | 55.3 a | 13.0 a | 4.3 a | 82.6 b |
| D | 5.0 a | 33.3 b | 61.7 b | 18.5 a | 24.1 a | 57.4 a | 17.0 a | 36.2 b | 46.8 ab | 0.0 a | 39.1 b | 60.9 b |
| K | 41.7 a | 23.3 ab | 35.0 b | 27.8 a | 20.4 a | 51.9 a | 38.3 a | 23.4 a | 38.3 a | 56.5 a | 13.0 ab | 30.4 b |
| N | 33.3 a | 23.3 a | 43.3 a | 44.4 a | 24.1 a | 31.5 a | 31.9 ab | 36.2 b | 31.9 a | 21.7 a | 52.2 b | 26.1 a |
| APR | 18.3 a | 20.0 a | 61.7 a | 24.1 a | 5.6 a | 70.4 b | 17.0 a | 19.1 ab | 63.8 b | 17.4 a | 17.4 a | 65.2 a |
| TIC | 28.3 a | 11.7 a | 60.0 a | 37.0 a | 18.5 a | 44.4 a | 44.7 a | 21.3 a | 34.0 a | 34.8 a | 13.0 a | 52.2 a |
| AMC | 23.3 a | 10.0 a | 66.7 a | 50.0 a | 7.4 ab | 42.6 b | 42.6 a | 23.4 a | 34.0 a | 21.7 a | 13.0 a | 65.2 a |
| CR | 15.0 a | 8.3 a | 76.7 b | 22.2 a | 3.7 a | 74.1 b | 14.9 a | 8.5 a | 76.6 b | 13.0 a | 0.0 a | 87.0 b |
| SXT | 36.1 a | 25.0 a | 38.9 a | 38.2 a | 20.6 a | 41.2 a | 34.3 a | 11.4 a | 54.3 a | 71.4 a | 7.1 ab | 21.4 b |
| FOX | 55.6 a | 19.4 ab | 25.0 b | 32.4 a | 38.2 b | 29.4 a | 41.4 a | 25.7 ab | 22.9 b | 64.3 a | 21.4 ab | 14.3 b |
| OT | 33.3 a | 22.2 a | 44.4 a | 36.4 ab | 39.4 b | 24.2 a | 50.0 a | 17.6 a | 32.4 a | 15.4 ab | 53.8 b | 30.8 a |
GM: gentamicin; AK: amikacin; AMP: ampicillin; P: penicillin; D: doxycycline; K: kanamycin; N: neomycin; APR: apramycin; TIC: ticarcillin; AMC: amoxicillin/clavulanic acid; CR: cephaloridine; SXT: trimethoprim-sulphonamide; FOX: cefoxitin; OT: oxytetracycline.